Dec 10, 2019: Roche announced that it has obtained the CE Mark for its Accu-Chek SugarView app, innovative diabetes management solution in Europe and further countries around the world requiring the CE Mark.
Officially classified as in-vitro diagnostics (IVD) software, this app will be made extensively accessible by Roche first for certain smartphone models via the Google Play Store and thus enabling broader access to therapy relevant information for the non-insulin dependent people with type 2 diabetes or pre-diabetes.
This App determines the blood glucose range using the Accu-Chek Active test strip and two phot os taken off the strip with a smartphone camera and follow step-by-step guide leads the user through the testing process.
A dedicated algorithm on the blood glucose result on the test strip to one of the categories varing from “low” to “very high”.
Also, based on the testing result, it can combine the blood glucose range with basic information on how to take action, such as exercise or eating. https://www.roche.com/media/releases/med-cor-2019-12-10.htm
